Cargando…
The association between anti‐acetylcholine receptor antibody level and clinical improvement in myasthenia gravis
BACKGROUND AND PURPOSE: Anti‐acetylcholine receptor (AChR) antibodies (ab) in the serum are detected in most patients with generalized myasthenia gravis (MG) and used as a diagnostic tool. The aim of this study was to analyse a possible association between anti‐AChR‐ab serum levels and clinical impr...
Autores principales: | Marcuse, Florit, Brandts, Lloyd, Moens, Daan, Damoiseaux, Jan, Hochstenbag, Monique, Hoeijmakers, Janneke G. J., Maessen, Jos G., De Baets, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303954/ https://www.ncbi.nlm.nih.gov/pubmed/34967067 http://dx.doi.org/10.1111/ene.15238 |
Ejemplares similares
-
Myasthenia gravis in clinical practice
por: Estephan, Eduardo de Paula, et al.
Publicado: (2022) -
Prognosis in Pediatric Myasthenia Gravis
por: Krueger, Jena
Publicado: (2020) -
Eculizumab versus rituximab in generalised myasthenia gravis
por: Nelke, Christopher, et al.
Publicado: (2022) -
Thymectomy in myasthenia gravis: “The real world” experience beyond studies
por: Waheed, Waqar, et al.
Publicado: (2022) -
Short‐term and sustained clinical response following thymectomy in patients with myasthenia gravis
por: Rath, Jakob, et al.
Publicado: (2022)